解放军医学杂志2021年7月28日第46卷第7期
642
ClinKidneyJ,2021,14(3):768-779.
etal
[6]WheltonPK,CareyRM,AronowWS,.2017ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNAGuidelinefor
theprevention,detection,evaluation,andmanagementofhighbloodpressureinadults:AreportoftheAmericanCollegeofCardiology/
AmericanHeartAssociationTaskForceonClinicalPracticeGuidelines[J].JAmCollCardiol,2018,71(19):e127-e248.
etal
[7]WilliamsB,ManciaG,SpieringW,.2018ESC/ESHGuidelinesforthemanagementofarterialhypertension:TheTaskForceforthe
managementofarterialhypertensionoftheEuropeanSocietyofCardiologyandtheEuropeanSocietyofHypertension[J].JHypertens,2018,
36(10):1953-2041.
etal
[8]RabiDM,McBrienKA,Sapir-PichhadzeR,.HypertensionCanada''s2020comprehensiveguidelinesfortheprevention,diagnosis,risk
assessment,andtreatmentofhypertensioninadultsandchildren[J].CanJCardiol,2020,36(5):596-624.
[9]ChineseNephrologistAssociation,RenalDiseaseCommitteeofChineseAssociationofIntegratedMedicine.Chineseguidelinesforrenal
hypertensionmanagement2016[J].NatlMedJChina,2017,97(20):1547-1555.[中国医师协会肾脏内科医师分会,中国中西医结合学
会肾脏疾病专业委员会.中国肾性高血压管理指南2016[J].中华医学杂志,2017,97(20):1547-1555.]
etal
[10]NinomiyaT,PerkovicV,TurnbullF,.Bloodpressureloweringandmajorcardiovasculareventsinpeoplewithandwithoutchronickidney
disease:meta-analysisofrandomisedcontrolledtrials[J].BMJ,2013,347:f5680.
etal
[11]BeddhuS,ChertowGM,GreeneT,.Effectsofintensivesystolicbloodpressureloweringoncardiovasculareventsandmortalityinpatients
withtype2diabetesmellitusonstandardglycemiccontrolandinthosewithoutdiabetesmellitus:reconcilingresultsfromACCORDBPand
SPRINT[J].JAmHeartAssoc,2018,7(18):e009326.
etal
[12]SolimanEZ,AmbrosiusWT,CushmanWC,.Effectofintensivebloodpressureloweringonleftventricularhypertrophyinpatientswith
hypertension:SPRINT(systolicbloodpressureinterventiontrial)[J].Circulation,2017,136(5):440-450.
etal
[13]XieX,LiuY,PerkovicV,.Renin-angiotensinsysteminhibitorsandkidneyandcardiovascularoutcomesinpatientswithCKD:aBayesian
networkMeta-analysisofrandomizedclinicaltrials[J].AmJKidneyDis,2016,67(5):728-741.
etal
[14]MaschioG,AlbertiD,JaninG,.Effectoftheangiotensin-converting-enzymeinhibitorbenazeprilontheprogressionofchronicrenal
insufficiency.TheAngiotensin-Converting-EnzymeInhibitioninProgressiveRenalInsufficiencyStudyGroup[J].NEnglJMed,1996,
334(15):939-945.
etal
[15]RuggenentiP,PernaA,GherardiG,.RenoprotectivepropertiesofACE-inhibitioninnon-diabeticnephropathieswithnon-nephrotic
proteinuria[J].Lancet,1999,354(9176):359-364.
etal
[16]HouFF,ZhangX,ZhangGH,.Efficacyandsafetyofbenazeprilforadvancedchronicrenalinsufficiency[J].NEnglJMed,2006,354(2):
131-140.
etal
[17]WrightJTJr,BakrisG,GreeneT,.Effectofbloodpressureloweringandantihypertensivedrugclassonprogressionofhypertensivekidney
disease:resultsfromtheAASKtrial[J].JAMA,2002,288(19):2421-2431.
etal
[18]BakrisGL,AgarwalR,AnkerSD,.Effectoffinerenoneonchronickidneydiseaseoutcomesintype2diabetes[J].NEnglJMed,2020,
383(23):2219-2229.
etal
[19]PisanoA,BolignanoD,MallamaciF,.Comparativeeffectivenessofdifferentantihypertensiveagentsinkidneytransplantation:a
systematicreviewandmeta-analysis[J].NephrolDialTransplant,2020,35(5):878-887.
[20]SarafidisPA,RuilopeLM.Aggressivebloodpressurereductionandrenin-angiotensinsystemblockadeinchronickidneydisease:timeforre-
evaluation?[J].KidneyInt,2014,85(3):536-546.
etal
[21]ESCAPETrialGroup,WühlE,TrivelliA,.Strictblood-pressurecontrolandprogressionofrenalfailureinchildren[J].NEnglJMed,
2009,361(17):1639-1650.
etal
[22]vandenBeltSM,HeerspinkHJL,GracchiV,.Earlyproteinurialoweringbyangiotensin-convertingenzymeinhibitionpredictsrenal
survivalinchildrenwithCKD[J].JAmSocNephrol,2018,29(8):2225-2233.
(收稿日期：2021-04-08；修回日期：2021-06-27)
(责任编辑：张小利) |
|
